Dr. Erica L Torgrude, DPM Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7509 Big Bend Blvd, Webster Groves, MO 63119 Phone: 314-961-3113 Fax: 314-968-7529 |
News Archive
Cytori Therapeutics was informed that positive longer-term follow-up data were presented from an independent, investigator-sponsored breast reconstruction study in Japan.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has made the latest in its series of educational webinars available to watch online at www.ogt.com/webinars. In the webinar entitled "Developing new insights into gene expression using RNA-Seq", Dr Christopher Jones, Research Fellow at the Brighton and Sussex Medical School (BSMS), UK, presents novel findings from a recent RNA-Seq project performed by OGT.
Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.
Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.
Two protocols for quickly and safely evaluating patients presenting to emergency departments with chest pain are being adopted by Australian hospitals.
› Verified 8 days ago